ORG is an organoid-specialized
biotechnology company, transforming
medical research and drug development
through advanced stem cell and
organoid technologies.
Through the commercialization of 3D cell culture systems and continued innovation in organoid research, we address the increasing demand for human-relevant testing methods that reduce reliance on animal models and support the global transition toward New Approach Methodologies (NAMs). Our innovative organoid platforms enable researchers in Korea and worldwide to conduct drug development and disease research with greater precision, reproducibility, and ethical responsibility.
ORG aims to become a leading provider of next-generation testing solutions, advancing beyond the limitations of conventional experimental models. We are committed to developing innovative biotechnology solutions that contribute to better human health and quality of life
